Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan.

[1]  M. Vahter,et al.  Lack of methylation of inorganic arsenic in the chimpanzee. , 1995, Toxicology and applied pharmacology.

[2]  G. Chenevix-Trench,et al.  Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. , 1995, Carcinogenesis.

[3]  M. Spitz,et al.  Ethnic differences in the prevalence of the homozygous deleted genotype of glutathione S-transferase theta. , 1995, Carcinogenesis.

[4]  E. I. Hamilton,et al.  Arsenic in the environment part II: Human health and ecosystem effects , 1995 .

[5]  Y. Hsueh,et al.  Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. , 1995, Cancer research.

[6]  H. Keizer,et al.  In vivo characterization and modulation of the glutathione/glutathione S-transferase system in cancer patients. , 1995, Drug metabolism reviews.

[7]  J. Brockmöller,et al.  Glutathione S-transferase M1 and its variants A and B as host factors of bladder cancer susceptibility: a case-control study. , 1994, Cancer research.

[8]  H. Bolt,et al.  Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. , 1994, The Biochemical journal.

[9]  D. Bernstein,et al.  Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. , 1994, Carcinogenesis.

[10]  R. Strange,et al.  Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours , 1994, The Lancet.

[11]  D. Thompson,et al.  A chemical hypothesis for arsenic methylation in mammals. , 1993, Chemico-biological interactions.

[12]  N K Spurr,et al.  Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. , 1993, Carcinogenesis.

[13]  W. Willett,et al.  Toenail trace element levels as biomarkers: reproducibility over a 6-year period. , 1993, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[14]  Jack A. Taylor,et al.  Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. , 1993, Journal of the National Cancer Institute.

[15]  J. Brockmöller,et al.  Genotype and Phenotype of Glutathione S-Transferase Class µ Isoenzymes µ and ψ in Lung Cancer Patients and Controls , 1993 .

[16]  J. D. Goeij,et al.  The significance of hair mineral analysis as a means for assessing internal body burdens of environmental pollutants: Results from an IAEA Co-ordinated Research Programme , 1993 .

[17]  T. Kuo,et al.  Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. , 1992, British Journal of Cancer.

[18]  A. Smith,et al.  Cancer risks from arsenic in drinking water. , 1992, Environmental health perspectives.

[19]  P Linko,et al.  Glutathione S-transferase mu in human lymphocyte and liver: role in modulating formation of carcinogen-derived DNA adducts. , 1991, Carcinogenesis.

[20]  C. Wolf,et al.  Glutathione S-transferase mu locus: use of genotyping and phenotyping assays to assess association with lung cancer susceptibility. , 1991, Carcinogenesis.

[21]  G. van Belle,et al.  The effect of variable environmental arsenic contamination on urinary concentrations of arsenic species. , 1990, Environmental health perspectives.

[22]  J. Buchet,et al.  Inorganic arsenic methylation by rat tissue slices. , 1990, Toxicology.

[23]  J. G. Farmer,et al.  Assessment of occupational exposure to inorganic arsenic based on urinary concentrations and speciation of arsenic. , 1990, British journal of industrial medicine.

[24]  G. Webb,et al.  Genetic heterogeneity of the human glutathione transferases: a complex of gene families. , 1990, Pharmacology & therapeutics.

[25]  H. Yamauchi,et al.  Biological monitoring of arsenic exposure of gallium arsenide- and inorganic arsenic-exposed workers by determination of inorganic arsenic and its metabolites in urine and hair. , 1989, American Industrial Hygiene Association journal.

[26]  Chien-Jen Chen,et al.  Atherogenicity and Carcinogenicity of High‐Arsenic Artesian Well Water: Multiple Risk Factors and Related Malignant Neoplasms of Blackfoot Disease , 1988, Arteriosclerosis.

[27]  J. Buchet,et al.  Role of thiols in the in-vitro methylation of inorganic arsenic by rat liver cytosol. , 1988, Biochemical pharmacology.

[28]  T. Kuo,et al.  ARSENIC AND CANCERS , 1988, The Lancet.

[29]  J. Buchet,et al.  Study of factors influencing the in vivo methylation of inorganic arsenic in rats. , 1987, Toxicology and applied pharmacology.

[30]  E. Marafante,et al.  Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit. , 1987, Toxicology letters.

[31]  E Marafante,et al.  Solubility, retention, and metabolism of intratracheally and orally administered inorganic arsenic compounds in the hamster. , 1987, Environmental research.

[32]  Y. Ohmori,et al.  Trace elements in human hair: An international comparison , 1986, Bulletin of environmental contamination and toxicology.

[33]  S. You,et al.  A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. , 1986, British Journal of Cancer.

[34]  E. Marafante,et al.  The role of the methylation in the detoxication of arsenate in the rabbit. , 1985, Chemico-biological interactions.

[35]  C. J. Chen,et al.  Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. , 1985, Cancer research.

[36]  G. Gordon.  Sex and age related differences in trace element concentrations in hair. , 1985, The Science of the total environment.

[37]  E. Marafante,et al.  Tissue distribution and retention of74As-dimethylarsinic acid in mice and rats , 1984 .

[38]  E. Marafante,et al.  Intracellular interaction and metabolic fate of arsenite and arsenate in mice and rabbits. , 1983, Chemico-biological interactions.

[39]  M. Vahter,et al.  Biotransformation of trivalent and pentavalent inorganic arsenic in mice and rats. , 1981, Environmental research.

[40]  H. Roels,et al.  Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man , 1981, International archives of occupational and environmental health.

[41]  H. Roels,et al.  Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers , 1981, International archives of occupational and environmental health.

[42]  S. Charbonneau,et al.  Metabolism of inorganic arsenic (74As) in humans following oral ingestion. , 1979, Toxicology and applied pharmacology.

[43]  W. Tseng.  Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic , 1977, Environmental health perspectives.

[44]  R. Braman.  Arsenic in the environment , 1975 .

[45]  W. Tseng,et al.  Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. , 1968, Journal of the National Cancer Institute.

[46]  J. Phillips,et al.  QUESTIONS PUT TO THE MEDICAL PRACTITIONERS OF NOTTINGHAM BY THE FACTORY COMMISSION. , 1833 .